Increased TLR activation drives inflammation through NF-κB (Mogi et al., 2007; Reynolds et al., 2008; Pranski et al., 2013) and activates the inflammasome, which has been increasingly linked to PD pathology (Gordon et al., 2018; von Herrmann et al., 2018). Here, NFKB1 is linked to Parkinson disease.